Article
Canakinumab for the treatment of familial Mediterranean fever.
Expert review of clinical immunology - 1 May 2017
Ozdogan Huri, Ugurlu Serdal
Abstract excerpt
INTRODUCTION: Familial Mediterranean fever (FMF) is the most frequent of all hereditary autoinflammatory syndromes. It is characterized by recurrent attacks of fever and serositis. If not treated it may be complicated with AA amyloidosis. It is caused by mutations in the MEFV gene that encodes pyrin which is involved in the regulation of IL-1β. The mainstay of treatment is colchicine, however a subset of patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
